AAAAAA

   
Results: 1-21 |
Results: 21
SYMPTOMATIC CARDIOTOXICITY ASSOCIATED WITH 5-FLUOROURACIL
Authors: MEYER CC CALIS KA BURKE LB WALAWANDER CA GRASELA TH
Citation: Cc. Meyer et al., SYMPTOMATIC CARDIOTOXICITY ASSOCIATED WITH 5-FLUOROURACIL, Pharmacotherapy, 17(4), 1997, pp. 729-736
BYPASSING THE PACU - A NEW PARADIGM IN AMBULATORY SURGERY
Authors: APFELBAUM JL GRASELA TH WALAWANDER CA BARASH P BARTON C KAPUR P KOPMAN A KORTTILA K MCLESKEY C PALMER J ROIZEN M SHAUGHNESSY R WATKINS D WETCHLER B PALLAIS S
Citation: Jl. Apfelbaum et al., BYPASSING THE PACU - A NEW PARADIGM IN AMBULATORY SURGERY, Anesthesiology, 87(3), 1997, pp. 32-32
BENCHMARKING DATA TO MODIFY PRACTICE REDUCES AMBULATORY SURGICAL CENTER EXPENSES
Authors: APFELBAUM JL GRASELA TH WALAWANDER CA BARASH P BARTON C KAPUR P KOPMAN A KORTTILA K MCLESKEY C PALMER J ROIZEN M SHAUGHNESSY R WATKINS D WETCHLER B PALLAIS S
Citation: Jl. Apfelbaum et al., BENCHMARKING DATA TO MODIFY PRACTICE REDUCES AMBULATORY SURGICAL CENTER EXPENSES, Anesthesiology, 87(3), 1997, pp. 963-963
ADVERSE DRUG REACTION REPORTING IN A MULTICENTER SURVEILLANCE STUDY
Authors: TIMM EG WELAGE LS WALAWANDER CA SAYERS JFB KARPIUK EL DAVIS TD GRASELA TH
Citation: Eg. Timm et al., ADVERSE DRUG REACTION REPORTING IN A MULTICENTER SURVEILLANCE STUDY, The Annals of pharmacotherapy, 29(3), 1995, pp. 240-245
PRETREATMENT REGIMENS FOR ADVERSE EVENTS RELATED TO INFUSION OF AMPHOTERICIN-B
Authors: GOODWIN SD CLEARY JD WALAWANDER CA TAYLOR JW GRASELA TH
Citation: Sd. Goodwin et al., PRETREATMENT REGIMENS FOR ADVERSE EVENTS RELATED TO INFUSION OF AMPHOTERICIN-B, Clinical infectious diseases, 20(4), 1995, pp. 755-761
SEPSIS SYNDROME AND ASSOCIATED SEQUELAE IN PATIENTS AT HIGH-RISK FOR GRAM-NEGATIVE SEPSIS
Authors: CONBOY K WELAGE LS WALAWANDER CA DUFFY LC WELLIVER RC ZIELEZNY MA DIPIRO JT RAEBEL MA GRASELA TH
Citation: K. Conboy et al., SEPSIS SYNDROME AND ASSOCIATED SEQUELAE IN PATIENTS AT HIGH-RISK FOR GRAM-NEGATIVE SEPSIS, Pharmacotherapy, 15(1), 1995, pp. 66-77
THE PUBLICATION OF COMMERCIALLY SUPPORTED SUPPLEMENTS STATEMENT - RESPONSE
Authors: APFELBAUM JL GRASELA TH HUG CC MCLESKEY CH NAHRWOLD ML STANLEY TH THISTED RA WALAWANDER CA WHITE PF
Citation: Jl. Apfelbaum et al., THE PUBLICATION OF COMMERCIALLY SUPPORTED SUPPLEMENTS STATEMENT - RESPONSE, Anesthesia and analgesia, 81(4), 1995, pp. 888-889
ALTERNATIVES TO INTRAVENOUS TETRACYCLINE HYDROCHLORIDE FOR MALIGNANT PLEURAL EFFUSIONS
Authors: GRASELA TH WALAWANDER CA JOLSON HM KENNEDY DL
Citation: Th. Grasela et al., ALTERNATIVES TO INTRAVENOUS TETRACYCLINE HYDROCHLORIDE FOR MALIGNANT PLEURAL EFFUSIONS, The Annals of pharmacotherapy, 28(7-8), 1994, pp. 968-969
RISK-FACTORS FOR ACUTE RENAL-INSUFFICIENCY IN PATIENTS WITH SUSPECTEDOR DOCUMENTED BACTERIAL PNEUMONIA
Authors: WELAGE LS WALAWANDER CA TIMM EG GRASELA TH
Citation: Ls. Welage et al., RISK-FACTORS FOR ACUTE RENAL-INSUFFICIENCY IN PATIENTS WITH SUSPECTEDOR DOCUMENTED BACTERIAL PNEUMONIA, The Annals of pharmacotherapy, 28(4), 1994, pp. 515-522
USE OF ANTIFUNGAL THERAPY IN HOSPITALIZED-PATIENTS .1. RESULTS PRIOR TO THE MARKETING OF FLUCONAZOLE
Authors: GRASELA TH GOODWIN SD PASKO MT WALAWANDER CA RAEBEL MA
Citation: Th. Grasela et al., USE OF ANTIFUNGAL THERAPY IN HOSPITALIZED-PATIENTS .1. RESULTS PRIOR TO THE MARKETING OF FLUCONAZOLE, The Annals of pharmacotherapy, 28(2), 1994, pp. 252-260
USE OF ANTIFUNGAL THERAPY IN HOSPITALIZED-PATIENTS .2. RESULTS AFTER THE MARKETING OF FLUCONAZOLE
Authors: GRASELA TH PASKO MT GOODWIN SD WALAWANDER CA BLACKWELDER N BRUDERHOLT RJ
Citation: Th. Grasela et al., USE OF ANTIFUNGAL THERAPY IN HOSPITALIZED-PATIENTS .2. RESULTS AFTER THE MARKETING OF FLUCONAZOLE, The Annals of pharmacotherapy, 28(2), 1994, pp. 261-270
ANALYSIS OF POTENTIAL RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OFPANCREATITIS IN PHASE-I PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX RECEIVING DIDANOSINE
Authors: GRASELA TH WALAWANDER CA BELTANGADY M KNUPP CA MARTIN RR DUNKLE LM BARBHAIYA RH PITTMAN KA DOLIN R VALENTINE FT LIEBMAN HA
Citation: Th. Grasela et al., ANALYSIS OF POTENTIAL RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OFPANCREATITIS IN PHASE-I PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX RECEIVING DIDANOSINE, The Journal of infectious diseases, 169(6), 1994, pp. 1250-1255
THE CLINICAL-EVALUATION OF NEW DRUGS FOR SEPSIS - A PROSPECTIVE-STUDYDESIGN BASED ON SURVIVAL ANALYSIS
Authors: KNAUS WA HARRELL FE FISHER CJ WAGNER DP OPAL SM SADOFF JC DRAPER EA WALAWANDER CA CONBOY K GRASELA TH
Citation: Wa. Knaus et al., THE CLINICAL-EVALUATION OF NEW DRUGS FOR SEPSIS - A PROSPECTIVE-STUDYDESIGN BASED ON SURVIVAL ANALYSIS, JAMA, the journal of the American Medical Association, 270(10), 1993, pp. 1233-1241
ADVERSE EVENTS IN A MULTICENTER PHASE-IV STUDY OF PROPOFOL - EVALUATION BY ANESTHESIOLOGISTS AND POSTANESTHESIA CARE UNIT NURSES
Authors: MCLESKEY CH WALAWANDER CA NAHRWOLD ML ROIZEN MF STANLEY TH THISTED RA WHITE PF APFELBAUM JL GRASELA TH HUG CC
Citation: Ch. Mcleskey et al., ADVERSE EVENTS IN A MULTICENTER PHASE-IV STUDY OF PROPOFOL - EVALUATION BY ANESTHESIOLOGISTS AND POSTANESTHESIA CARE UNIT NURSES, Anesthesia and analgesia, 77(4), 1993, pp. 3-9
THE INITIAL CLINICAL-EXPERIENCE OF 1819 PHYSICIANS IN MAINTAINING ANESTHESIA WITH PROPOFOL - CHARACTERISTICS ASSOCIATED WITH PROLONGED TIMETO AWAKENING
Authors: APFELBAUM JL GRASELA TH HUG CC MCLESKEY CH NAHRWOLD ML ROIZEN MF STANLEY TH THISTED RA WALAWANDER CA WHITE PF
Citation: Jl. Apfelbaum et al., THE INITIAL CLINICAL-EXPERIENCE OF 1819 PHYSICIANS IN MAINTAINING ANESTHESIA WITH PROPOFOL - CHARACTERISTICS ASSOCIATED WITH PROLONGED TIMETO AWAKENING, Anesthesia and analgesia, 77(4), 1993, pp. 10-14
EFFECTS ON RECOVERY WHEN ISOFLURANE IS USED TO SUPPLEMENT PROPOFOL-NITROUS OXIDE ANESTHESIA
Authors: WHITE PF STANLEY TH APFELBAUM JL GRASELA TH HUG CC MCLESKEY CH NAHRWOLD ML ROIZEN MF THISTED RA WALAWANDER CA
Citation: Pf. White et al., EFFECTS ON RECOVERY WHEN ISOFLURANE IS USED TO SUPPLEMENT PROPOFOL-NITROUS OXIDE ANESTHESIA, Anesthesia and analgesia, 77(4), 1993, pp. 15-20
HEMODYNAMIC-EFFECTS OF PROPOFOL - DATA FROM OVER 25,000 PATIENTS
Authors: HUG CC MCLESKEY CH NAHRWOLD ML ROIZEN MF STANLEY TH THISTED RA WALAWANDER CA WHITE PF APFELBAUM JL GRASELA TH
Citation: Cc. Hug et al., HEMODYNAMIC-EFFECTS OF PROPOFOL - DATA FROM OVER 25,000 PATIENTS, Anesthesia and analgesia, 77(4), 1993, pp. 21-29
HOW DO ANESTHESIOLOGISTS SELECT PATIENTS WHEN INTRODUCING A NEW DRUG INTO PRACTICE
Authors: ROIZEN MF STANLEY TH THISTED RA WALAWANDER CA WHITE PF APFELBAUM JL GRASELA TH HUG CC MCLESKEY CH NAHRWOLD ML
Citation: Mf. Roizen et al., HOW DO ANESTHESIOLOGISTS SELECT PATIENTS WHEN INTRODUCING A NEW DRUG INTO PRACTICE, Anesthesia and analgesia, 77(4), 1993, pp. 30-33
PHASE-IV STUDY OF PROPOFOL - VALIDATION OF THE DATA SET
Authors: NAHRWOLD ML ROIZEN MF STANLEY TH THISTED RA WALAWANDER CA WHITE PF APFELBAUM JL GRASELA TH HUG CC MCLESKEY CH
Citation: Ml. Nahrwold et al., PHASE-IV STUDY OF PROPOFOL - VALIDATION OF THE DATA SET, Anesthesia and analgesia, 77(4), 1993, pp. 34-43
THE ROLE OF PHARMACOEPIDEMIOLOGY RESEARCH IN POSTMARKETING SURVEILLANCE AND ANESTHESIA PRACTICE CRITICAL CARE MEDICINE
Authors: GRASELA TH WATKINS WD HUG CC MCLESKEY CH NAHRWOLD ML ROIZEN MF STANLEY TH THISTED RA WALAWANDER CA WHITE PF APFELBAUM JL
Citation: Th. Grasela et al., THE ROLE OF PHARMACOEPIDEMIOLOGY RESEARCH IN POSTMARKETING SURVEILLANCE AND ANESTHESIA PRACTICE CRITICAL CARE MEDICINE, Anesthesia and analgesia, 77(4), 1993, pp. 44-50
CAPABILITY OF HOSPITAL COMPUTER-SYSTEMS IN PERFORMING DRUG-USE EVALUATIONS AND ADVERSE DRUG EVENT MONITORING
Authors: GRASELA TH WALAWANDER CA KENNEDY DL JOLSON HM
Citation: Th. Grasela et al., CAPABILITY OF HOSPITAL COMPUTER-SYSTEMS IN PERFORMING DRUG-USE EVALUATIONS AND ADVERSE DRUG EVENT MONITORING, American journal of hospital pharmacy, 50(9), 1993, pp. 1889-1895
Risultati: 1-21 |